18.6001.36% ( +0.250 )
Closed: Nov 13, 16:00:00 (EDT)Overview
Mentari Therapeutics (MTRI)
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company’s products include MT-001, an anti-PAC...
- Open
- 19.020
- High
- 20.000
- Low
- 18.400
- Prev. Close
- 18.350
- Volume
- 11.96K
- Turnover
- 226.57K
- Avg Price
- 18.947
- Bid/Ask Ratio
- -33.33%
- Amplitude
- 8.72%
- 52wk High
- 23.300
- Volume Ratio
- 0.00
- Turnover Ratio
- 4.66%
- 52wk Low
- 5.750
- Float Mkt Cap
- 4.77M
- Market CapUSD
- 10.22M
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- 256.46K
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 549.37K
- Min lot size
- 1
- Currency
- USD
Mentari Therapeutics Analyst Rating
View moreForecast & Rating
Nov 11, 2026Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
benzinga_article · This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Market Movers · Mentari Therapeutics climbs 9%
TradingView · Wedbush initiates coverage of Mentari Therapeutics at Outperform, sets price target at $33
PUBT · Mentari Therapeutics Files Initial Beneficial Ownership Statement for Director Julianne Bruno
Market Movers · Mentari Therapeutics surges 20%
Simplywall · Why Did Mentari Therapeutics (MTRI) Move Today?
